RSM logo
Journal of Telemedicine and Telecare

Home Current issue Browse archive Alerts About the journal Feedback
 
J Telemed Telecare 2009;15:362-367
doi:10.1258/jtt.2009.090405
© 2009 Royal Society of Medicine Press

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Vrijhoef, H. J.
Right arrow Articles by Greenberg, M. E
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

RESEARCH

Original articles

Feasibility of telemonitoring for active surveillance of influenza vaccine safety in the primary care setting in the Netherlands

Hubertus JM Vrijhoef * {dagger} , Joyce JM Janssen {dagger} and Michael E Greenberg {ddagger}


* Research Institute for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre, Maastricht; {dagger} Department of Integrated Care, Maastricht University Medical Centre, Maastricht, The Netherlands; {ddagger} GlaxoSmithKline Biologicals, Rixensart, Belgium


Correspondence: Dr Hubertus JM Vrijhoef, PO Box 616, 6200 MD Maastricht, The Netherlands (Fax: +31 43 388 4162; Email: B.Vrijhoef{at}ZW.unimaas.nl)


We examined the feasibility of a commercial home telemonitoring system for monitoring adverse events related to vaccination and influenza-like illness (ILI) signs and outcomes in the primary care setting in the Netherlands. A prospective cohort of people eligible for influenza vaccination was monitored daily between mid-October 2007 and mid-March 2008. Adults from five primary care centres were invited to participate. A total of 245 people participated (response rate 75%). Their mean age was 61 years (SD = 15), 50% were female and 60% had a chronic disease. Most (73%) had no problems with installation of the system and 67% finished all sets of monitoring dialogues. The reported incidence of adverse events in the first week after vaccination was 8–38%. The reported incidence rates of ILI symptoms varied and were higher than reference data. A total of 39% of individuals consulted their general practitioner, 7% the hospital emergency department, 6% were hospitalized and 27% used medication. Of those in paid work, one-third reported absence of work due to ILI. Home telemonitoring appears to be feasible for monitoring vaccine adverse events and ILI symptoms and outcomes.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




MDU Exam Doctor